[artículo]
| Título : |
Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia : A translational link to humans |
| Tipo de documento: |
texto impreso |
| Autores: |
Joanna Caroline Neill, Autor ; Michael K. Harte, Autor ; Peter Haddad, Autor |
| Fecha de publicación: |
2021 |
| Artículo en la página: |
pp. 822-835 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Antagonistas del receptor NMDA, Síntomas negativos, Anhedonia, Retiro social, Modelos animales, Esquizofrenia, Motivación |
| Resumen: |
Negative symptoms of schizophrenia remain an unmet clinical need as they are common, persistent, respond poorly to existing treatments and lead to disability. Blunted affect, alogia, asociality, anhedonia and avolition are regarded as key negative symptoms despite DSM-IV-TR specifying a more limited range. |
| Link: |
./index.php?lvl=notice_display&id=26995 |
in European Neuropsychopharmacology > Año 2014 - Vol. 24 - No.5 (Mayo) . - pp. 822-835
[artículo] Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia : A translational link to humans [texto impreso] / Joanna Caroline Neill, Autor ; Michael K. Harte, Autor ; Peter Haddad, Autor . - 2021 . - pp. 822-835. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in European Neuropsychopharmacology > Año 2014 - Vol. 24 - No.5 (Mayo) . - pp. 822-835
| Palabras clave: |
Antagonistas del receptor NMDA, Síntomas negativos, Anhedonia, Retiro social, Modelos animales, Esquizofrenia, Motivación |
| Resumen: |
Negative symptoms of schizophrenia remain an unmet clinical need as they are common, persistent, respond poorly to existing treatments and lead to disability. Blunted affect, alogia, asociality, anhedonia and avolition are regarded as key negative symptoms despite DSM-IV-TR specifying a more limited range. |
| Link: |
./index.php?lvl=notice_display&id=26995 |
|
Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia en European Neuropsychopharmacology, Año 2014 - Vol. 24 - No.5 (Mayo)
